Form 4 for BMY Bristol Myers Squibb
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-01 · accession 0001753055-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-02-01 | BMY | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | +10.1K | 18.9K | +115% | $0 |
| D | 2026-02-03 | 2026-02-01 | BMY | Hickey Benjamin | Pres, RayzeBio Org | F - Tax | $55.05 | -3,810 | 15.1K | -20% | -$209.7K |
| D | 2026-02-03 | 2026-02-01 | BMY | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | -10.1K | 10.1K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2026-02-01 | M | A | 10,079 | $0.00 | 18,868 | D | — | — | (F1) The restricted stock units vest annually in three equal installments beginning on February 1, 2025. |
| 2 | Common | Common Stock, $0.10 par value | 2026-02-01 | F | D | 3,810 | $55.05 | 15,058 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2026-02-01 | M | D | 10,079 | $0.00 | 10,079 | D | — · — to 2027-02-01 | 10,079 Common Stock, $0.10 par value | (F3) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted stock units vest annually in three equal installments beginning on February 1, 2025. |